Imagine an 81.5 percent reduction in hospital-acquired pressure ulcers and a 6.4 percent reduction in length of stayall brought about by using a new type of bed linens and hospital gowns. DermaTherapy® is an engineered fabric that can replace the generic cotton blend used in traditional hospital linens and gowns.
The results of three clinical trials conducted at Cone Health hospitals are so compelling that Cone Health has become the first in the world to put bed linens, gowns and bed pads made from this patented antimicrobial fabric into its hospitals.
This is a breakthrough for patients everywhere. Far fewer patients develop bedsores, the wounds they have heal faster and a patients length of stay is shorter. Breakthrough is the perfect word to describe DermaTherapy, says Dr. Mary Jo Cagle, Chief Quality Officer, Cone Health.
The largest of the three trials of DermaTherapy products took place from December 2010 through May 2011 at Wesley Long Hospital in Greensboro, N.C., a part of the Cone Health network. Researchers found a 6.4 percent reduction in the length of stay for patients using DermaTherapy. Patients using DermaTherapy products developed 81.5 percent fewer pressure ulcers while in the hospital. The Wesley Long Hospital trial also found that upon discharge, patients who were admitted with bedsores had a 21 percent reduction in wounds, indicating that the linens promoted faster healing.
These therapeutic linens look like freshly pressed cotton but feel like silk. The fabric is smoother, drier and cleaner than the standard cotton blend used for hospital bedding and gowns. The smooth fabric reduces friction allowing the body to move more easily across the bed, making it less likely that a patients thin, weakened skin would tear and develop a pressure ulcer. The linens draw moisture away from the body faster and help regulate a patients skin temperature. This promotes healing.
It is hard to believe that the fabrics around a patient can improve the quality of care so much, says Annette Smith, RN, Vice President of Nursing, Cone Health. But they do. In fact, DermaTherapy items come back from the laundry with 92 percent fewer bacteria. That adds up to fewer new bacteria for a patient to battle and less time spent in the hospital.
DermaTherapy was originally created by Greensboro-based textile company Precision Fabrics Group Inc., in conjunction with Standard Textile Co. Inc. of Cincinnati, Ohio, to help people with skin conditions such as eczema and psoriasis. The companies suspected it may also reduce other skin conditions, such as pressure ulcers, and partnered with Cone Health to test the hypothesis.Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.